
Protein Language Models Market Report 2026
Global Outlook – By Component (Software, Hardware, Services), By Deployment Mode (On-Premises, Cloud), By Application (Drug Discovery, Protein Engineering, Disease Diagnosis, Functional Annotation, Other Applications), By End-User (Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Healthcare Providers, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Protein Language Models Market Overview
• Protein Language Models market size has reached to $0.97 billion in 2025 • Expected to grow to $3.05 billion in 2030 at a compound annual growth rate (CAGR) of 25.7% • Growth Driver: Expansion Of Precision Medicine And Personalized Therapeutics Fueling The Growth Of The Market Due To Rising Regulatory Approvals And Targeted Therapy Development • Market Trend: Innovations In Protein Language Models Accelerate Drug Discovery And Biological Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Protein Language Models Market?
Protein language models are artificial intelligence models designed to understand, represent, and predict the properties of proteins by learning patterns from amino acid sequences. These models can assist in protein design, function prediction, and understanding interactions at a molecular level. They help to accelerate research and development by providing computational insights into protein behavior. The main components of protein language model include software, hardware, and services. Software refers to platforms that enable organizations to analyze protein sequences, predict structures, and model biological functions using advanced machine learning and language model techniques. These solutions are deployed through on-premises and cloud models depending on organizational infrastructure and computational requirements. The various applications involved are drug discovery, Protein Engineering, disease diagnosis, functional annotation, and other applications. The end users of protein language model solutions include pharmaceutical and biotechnology companies, academic and research institutes, healthcare providers, and others.
What Is The Protein Language Models Market Size and Share 2026?
The protein language models market size has grown exponentially in recent years. It will grow from $0.97 billion in 2025 to $1.22 billion in 2026 at a compound annual growth rate (CAGR) of 25.5%. The growth in the historic period can be attributed to growth in genomic sequencing data, rising biopharma research spending, expansion of Bioinformatics platforms, increase in protein database availability, early adoption of machine learning in biology.What Is The Protein Language Models Market Growth Forecast?
The protein language models market size is expected to see exponential growth in the next few years. It will grow to $3.05 billion in 2030 at a compound annual growth rate (CAGR) of 25.7%. The growth in the forecast period can be attributed to increasing demand for computational protein design, expansion of AI led drug pipelines, rising need for rapid target identification, growing cross industry AI biology collaborations, higher investment in AI life science startups. Major trends in the forecast period include rising use of sequence based protein representation models, expansion of cloud hosted protein modeling platforms, growing demand for protein annotation services, increase in api based bioinformatics toolkits, higher adoption of AI driven drug discovery workflows.Global Protein Language Models Market Segmentation
1) By Component: Software; Hardware; Services 2) By Deployment Mode: On-Premises; Cloud 3) By Application: Drug Discovery; Protein Engineering; Disease Diagnosis; Functional Annotation; Other Applications 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Healthcare Providers; Other End-Users Subsegments: 1) By Software: Protein Sequence Analysis Platforms; Model Training And Fine Tuning Tools; Protein Structure Prediction Software; Protein Function Annotation Tools; Bioinformatics Integration Platforms 2) By Hardware: High Performance Computing Systems; Graphics Processing Hardware; Tensor Processing Hardware; Data Storage And Processing Systems; Cloud Based Computing Infrastructure 3) By Services: Consulting And Advisory Services; Custom Model Development Services; System Integration Services; Managed And Support Services; Training And Knowledge Transfer ServicesWhat Are The Drivers Of The Protein Language Models Market?
The expansion of precision medicine and personalized therapeutics is expected to propel the growth of the protein language models market going forward. Precision medicine and personalized therapeutics refer to healthcare approaches that tailor treatments to individual patient characteristics, such as genetic makeup, biomarkers, and disease profiles, to improve treatment effectiveness and reduce adverse outcomes. Precision medicine and personalized therapeutics are driven by increasing regulatory approvals, and research focuses on targeted therapies that address specific biological pathways rather than one-size-fits-all treatments. Protein language models support precision medicine by enabling detailed analysis of protein sequences and structures, helping researchers identify therapeutic targets, predict drug responses, and design patient-specific biological treatments more efficiently. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based not-for-profit organization, in 2023, the Food and Drug Administration (FDA) approved 16 new personalized therapies for rare disease patients, marking a sharp increase from six approvals in 2022. Therefore, the expansion of precision medicine and personalized therapeutics is driving the growth of the protein language models industry. The rising adoption of AI-driven drug discovery is expected to propel the growth of the protein language models market going forward. AI-driven drug discovery leverages artificial intelligence to accelerate the identification, design, and optimization of drug candidates through advanced analysis of large-scale biological and chemical data. The rise in adoption of artificial intelligence in drug discovery is due to its ability to accelerate target identification, optimize candidate selection, and improve research efficiency compared to traditional methods. Protein language models support drug discovery by using deep learning architectures to analyze protein sequences, predict structure–function relationships, and identify meaningful patterns that inform target selection and candidate optimization. For instance, in January 2025, according to the World Economic Forum, a Switzerland-based non-profit organization, approximately 30 percent of new drugs are discovered using AI technologies. Therefore, the rising adoption of AI-driven drug discovery is driving the growth of the protein language models industry.Key Players In The Global Protein Language Models Market
Major companies operating in the protein language models market are Google LLC, Meta Platforms Inc., Pfizer Inc., Novartis AG, AstraZeneca PLC, NVIDIA Corporation, Owkin Inc., Generate Biomedicines Inc., Recursion Pharmaceuticals Inc., BenevolentAI Limited, Exscientia plc, Dyno Therapeutics Inc., Atomwise Inc., ProteinQure Inc., Cradle Bio B.V., Profluent Bio Inc., BioMap (Beijing) Intelligence Technology Co. Ltd., EvolutionaryScale Inc., Isomorphic Labs Limited, Insilico Medicine Inc., AbSci Corporation, Peptone Ltd., and Valence Labs Inc.Global Protein Language Models Market Trends and Insights
Major companies operating in the protein language models market are focusing on developing advanced AI-driven protein language models to improve protein sequence analysis and accelerate drug discovery and biological research. An AI-driven protein language model uses artificial intelligence trained on large-scale protein sequences to predict, interpret, and generate protein structures and functions that accelerate protein engineering, mutation assessment, and the development of new therapeutic solutions. For instance, in September 2024, Ginkgo Bioworks Holdings, Inc., a US-based biotechnology company, launched a Protein Large Language Model and Model API built on Google Cloud technology. The solution is trained on Ginkgo’s proprietary protein dataset and hosted on Vertex AI, enabling enterprises and individual researchers to perform advanced protein sequence analysis and improve pattern recognition, thereby accelerating drug development and biological research workflows.nan
Regional Insights
North America was the largest region in the protein language models market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Protein Language Models Market?
The protein language models market consists of revenues earned by entities by providing services such as model training and fine-tuning, protein sequence annotation, structure and function prediction services, AI-driven drug discovery, cloud-based model hosting, bioinformatics consulting services, and custom model development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein language models market also includes sales of embedding generation tools, bioinformatics platforms, protein structure prediction tools, model training frameworks, and application programming interface toolkits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Protein Language Models Market Report 2026?
The protein language models market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the protein language models industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Protein Language Models Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.22 billion |
| Revenue Forecast In 2035 | $3.05 billion |
| Growth Rate | CAGR of 25.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Component, Deployment Mode, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Google LLC, Meta Platforms Inc., Pfizer Inc., Novartis AG, AstraZeneca PLC, NVIDIA Corporation, Owkin Inc., Generate Biomedicines Inc., Recursion Pharmaceuticals Inc., BenevolentAI Limited, Exscientia plc, Dyno Therapeutics Inc., Atomwise Inc., ProteinQure Inc., Cradle Bio B.V., Profluent Bio Inc., BioMap (Beijing) Intelligence Technology Co. Ltd., EvolutionaryScale Inc., Isomorphic Labs Limited, Insilico Medicine Inc., AbSci Corporation, Peptone Ltd., and Valence Labs Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
